[{"NetIncomeLoss_3_Q3_USD":-117838000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":45340000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":18029000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":24344000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":24000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":27411000.0,"Depreciation_3_Q3_USD":344000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":28000.0,"AssetsCurrent_0_Q3_USD":433013000.0,"PrepaidExpenseAndOtherAssets_0_Q3_USD":5101000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6947045.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":913000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":425000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":135000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":246786000.0,"CommonStockSharesIssued_0_Q3_shares":49208425.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":386791000.0,"Assets_0_Q3_USD":495275000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-17000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-1000.0,"ShareBasedCompensation_3_Q3_USD":26562000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1242000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingLeaseLiability_0_Q3_USD":1624000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":72332000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":22866000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1663000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":48417300.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48595420.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":8613000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-96000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-58000.0,"CommonStockValue_0_Q3_USD":5000.0,"InvestmentIncomeNet_3_Q3_USD":617000.0,"InvestmentIncomeNet_1_Q3_USD":179000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":449000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":913000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":480600000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-117855000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-41042000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1148000.0,"OtherAssetsNoncurrent_0_Q3_USD":2451000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":93852000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":367000.0,"Liabilities_0_Q3_USD":28597000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":-33000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-17000.0,"EquityMethodInvestments_0_Q3_USD":3184000.0,"LitigationSettlementExpense_3_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":39000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":301000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-1000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":52000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":26562000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":10712000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-81561000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":48417300.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":48595420.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":52731000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1297000.0,"LiabilitiesCurrent_0_Q3_USD":28099000.0,"AccountsPayableCurrent_0_Q3_USD":2498000.0,"NonoperatingIncomeExpense_3_Q3_USD":521000.0,"NonoperatingIncomeExpense_1_Q3_USD":121000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":94417000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":913000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":3230000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_3_Q3_USD":-2.43,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q3_USD":-0.84,"AdditionalPaidInCapital_0_Q3_USD":703090000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2089000.0,"NetIncomeLoss_1_Q3_USD":-41041000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-17000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-267000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-687000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"OperatingIncomeLoss_3_Q3_USD":-117672000.0,"OperatingIncomeLoss_1_Q3_USD":-40895000.0,"PreferredStockValue_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":495275000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5975000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":26562000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":10712000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1257000.0,"OperatingExpenses_3_Q3_USD":117672000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":231000.0,"OperatingExpenses_1_Q3_USD":40895000.0,"StockholdersEquity_0_Q3_USD":466678000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":512000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":386767000.0,"IncomeLossFromContinuingOperationsPerBasicShare_3_Q3_USD":-2.43,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q3_USD":-0.84,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-236441000.0,"MarketableSecurities_0_Q3_USD":334060000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-53237000.0,"CommonStockSharesOutstanding_0_Q3_shares":49208425.0,"RestrictedCashNoncurrent_0_Q3_USD":565000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":218863000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":131000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1393000.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]